Legal and organizational status
A department-level public-service institution directly under Zhejiang Province, operated with enterprise-style management.
INFORMATION ASYMMETRY · REGIONAL INNOVATION SYSTEM
How a platform jointly established by Zhejiang Province and Tsinghua University connects applied research, industry, finance and market use—and how its original model differs from PWSGROUP’s Korean adaptation.
Cross-checked against institute, Tsinghua and MOST sources plus supplied presentation materials · August 1, 2026
The institute is a public-service institution directly under the Zhejiang Provincial Government and a new-type R&D and commercialization platform jointly established with Tsinghua University. It uses enterprise-style management, but is neither a conventional branch campus, a private company nor a simple university liaison office.
Established under a 2003 Zhejiang–Tsinghua agreement and headquartered in Jiaxing, it combines a governing council, research institutes, regional cooperation and a technology-finance and investment platform.
A department-level public-service institution directly under Zhejiang Province, operated with enterprise-style management.
Jointly built by Zhejiang and Tsinghua, with a governing council reviewing leadership, annual work, assets and finances.
It positions itself between university-origin research and the applied research, pilot testing, productization and market scale that follow.
The two share a lineage of seven functions, but their wording, order and authorship differ. PWSGROUP’s formulation does not rename the institute’s model; it reorganizes the functions for Korean regional innovation and Korea–China execution.
The institute’s official sequence links public support, industry demand, universities, research, finance and technology intermediaries to market application.
PWSGROUP’s Korean practice framework starts with place, connects industry, academia, research and finance, tests real user demand, then uses professional intermediation to complete execution.
Rules, public platforms, regional coordination and early risk-sharing
Demand, co-development, production, supply chains and commercialization
Disciplines, talent, education and upstream research
Applied R&D, validation, prototypes, pilot testing and problem-solving
Investment, funds, banking and insurance for commercialization and growth
Transfer, IP, legal, accounting, standards, certification and matching
Real users, procurement, operating environments and purchase validation
Pairs R&D teams with commercialization entities and dedicated capital.
Combines research, pilot and production space, industrial clustering and finance.
Carries institute capabilities into county-level industry through local platforms, incubators and funds.
Sources and incubates projects offsite, then relocates teams, technology and capital into Zhejiang’s industrial setting.
A wholly owned investment platform uses direct and fund investment to support transfer and company growth.
The figures below are cumulative values reported by the institute or official sources through June 2026. Attraction, incubation, investment and cooperation describe different relationships; portfolio-company output and market value are not institute revenue or valuation.
Reported June 2026
Institute cumulative figure through June 2026
Reported June 2026; not the same as an investment portfolio
Cumulative through June 2026
Reported June 2026 cooperation footprint
Reported June 2026 by the institute
The phrase was already on display when Liu Yandong visited in 2010. The contemporary record confirms praise, not that she coined the name.
The reported 2,600-plus companies, 82 listed companies and state-enterprise partnerships refer to different relationships and must not be collapsed into ownership or spinout claims.
The 2025 output above RMB 700 billion and market value above RMB 2 trillion are aggregates for listed companies the institute says it invested in or developed—not institute revenue or valuation.
KOREA RESPONSE
Translate verified facts into actions for public bodies, industry, universities, research, finance, end users and professional services.
Build a standing platform that connects company technology demand, applied research, pilot testing, investment, field validation and procurement—not a sequence of short visits, events or MOUs. Document operating authority, shared funding, technology protection, data, export-control and reciprocity rules first, and start with real bottlenecks in the regional industrial base.
Evidence · joint-operating rules, responsible institutions and budgets, technology-protection, validation and procurement criteria / Indicators · paid projects, validation-to-procurement conversion, regional investment and jobs, follow-on funding
Make companies accountable participants—not passive sponsors—responsible for problem definition, data and site access, co-development, production and procurement. With Chinese partners, separate technology-disclosure limits, IP and data ownership, mass-production and delivery terms, and third-country business rights into staged contracts.
Evidence · technology-demand brief, co-development, IP and purchasing contracts, pilot logs / Indicators · development time, production conversion, purchases and sales, cost and quality improvement
Legally separate the university functions that produce papers and patents from commercialization companies, while linking them through dedicated staff and incentives. Agree in advance on the rights of faculty, students, universities and companies, outside appointments, and the sequence of publication and patent filing; then connect demand-validated projects to applied-research teams.
Evidence · joint-research, employee-invention, technology-transfer and outside-appointment rules / Indicators · follow-on projects, licensing income, pilot testing, startups and jobs
Focus on prototypes, pilot testing, standards, certification and field problem-solving that raise technology readiness, and open shared equipment and test methods to regional companies. Evaluate Chinese research outcomes through reproducibility tests under equivalent conditions and real-customer validation, not promotional figures.
Evidence · TRL criteria, equipment, test and standards records, company research contracts / Indicators · TRL movement, reproducibility, production conversion, equipment utilization and company access
Combine long-term capital, policy finance, guarantees and insurance to match R&D, pilot testing, initial production and growth stages. Independently assess each company’s IP, customers, cash flow, follow-on financing and exit path rather than relying on an institution’s brand or aggregate incubation figures.
Evidence · fund rules and paid-in capital, investment agreements, customers, sales and cash flow / Indicators · staged deployment, follow-on investment, private-capital participation, losses and exits
Define real operating conditions, safety and performance criteria, maintenance requirements and purchasing review from the start of technology development. Replace repeated unpaid PoCs with gates from small paid validation to production approval and repeat purchasing, so market use informs research from the outset rather than appearing only at the end.
Evidence · validation site, evaluation criteria, acceptance terms, SLA and purchasing intent / Indicators · paid validation, purchasing conversion and repeat orders, uptime, total cost of ownership
Connect technology, market, investment, legal, accounting, patent, standards and certification work within one project rather than merely making introductions. 介 means technology and professional intermediation. Disclose interested parties and fees, then cross-check original Chinese contracts, corporate records, IP and disbursements to reduce transaction costs and dispute risk.
Evidence · verification database, Chinese contracts, registrations, IP and disbursement records, fee and conflict disclosures / Indicators · contract conversion, commercialization time, risks found early, disputes and delays